|

Alirocumab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)1

Indications

  • Heavy Drinking Behavior1
  • Alcohol Associated Liver Disease1
  • Liver Disease1

Bethesda, Maryland1 trial

Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

National Institutes of Health Clinical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.